News on BioZone Laboratories%2C Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated BioZone Laboratories%2C Inc. news from BioPortfolio.com Wed, 10 Feb 2010 14:18:54 GMT en OlFactor Laboratories acquires exclusive license to patented technology from UC Riversidehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039853&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039853&THISHREF=http://c.moreover.com/click/here.pl%3fz2538431582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039853&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039853&THISHREF=http://c.moreover.com/click/here.pl%3fz2538431582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Zacks Analyst Blog Highlights: Becton, Dickinson and Company, Baxter International Inc., Johnson & Johnson, Abbott Laboratories and Nissan Motor Co. - Press Releaseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042086&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042086&THISHREF=http://c.moreover.com/click/here.pl%3fz2539307522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042086&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042086&THISHREF=http://c.moreover.com/click/here.pl%3fz2539307522%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBenzinga.com: Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato(R) Loxapine) in North Americahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041685&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041685&THISHREF=http://c.moreover.com/click/here.pl%3fz2539204871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041685&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041685&THISHREF=http://c.moreover.com/click/here.pl%3fz2539204871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Alexza Pharmaceuticals announces development and commercialization collaboration with Biovail Laboratories Internationalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041794&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041794&THISHREF=http://c.moreover.com/click/here.pl%3fz2539226410%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041794&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041794&THISHREF=http://c.moreover.com/click/here.pl%3fz2539226410%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Antares Pharma, Inc. - Financial And Strategic Analysis Review - New Report Publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034416&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034416&THISHREF=http://c.moreover.com/click/here.pl%3fz2535781097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034416&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034416&THISHREF=http://c.moreover.com/click/here.pl%3fz2535781097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOfficialWire: UC Riverside licenses technology to OlFactor Laboratories, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036440&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036440&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619155%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036440&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036440&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619155%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Updates for BioElectronics (OTC:BIEL), Borealis (OTC:BOREF), Charles River Laboratories (NYSE:CRL)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035380&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035380&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035380&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035380&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: UDATE 1-NeurogesX sees 'mid-tier' pain-patch pricehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032335&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032335&THISHREF=http://c.moreover.com/click/here.pl%3fz2534607077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032335&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032335&THISHREF=http://c.moreover.com/click/here.pl%3fz2534607077%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSharenet: Prometheus Makes Deal to Sell Skin and Kidney Cancer Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031275&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031275&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031275&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031275&THISHREF=http://c.moreover.com/click/here.pl%3fz2534115750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Diego Business Journal: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031117&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031117&THISHREF=http://c.moreover.com/click/here.pl%3fz2534002874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031117&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031117&THISHREF=http://c.moreover.com/click/here.pl%3fz2534002874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNN Money: CORRECTED-EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031081&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031081&THISHREF=http://c.moreover.com/click/here.pl%3fz2533982145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031081&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031081&THISHREF=http://c.moreover.com/click/here.pl%3fz2533982145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: CORRECTED-EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031071&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031071&THISHREF=http://c.moreover.com/click/here.pl%3fz2533974847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031071&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031071&THISHREF=http://c.moreover.com/click/here.pl%3fz2533974847%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030141&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030141&THISHREF=http://c.moreover.com/click/here.pl%3fz2533461787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030141&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030141&THISHREF=http://c.moreover.com/click/here.pl%3fz2533461787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: EU expected to clear Abbott, Solvay deal - sourceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030086&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533432435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030086&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030086&THISHREF=http://c.moreover.com/click/here.pl%3fz2533432435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USPhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030159&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030159&THISHREF=http://c.moreover.com/click/here.pl%3fz2533474020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030159&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BioZone%20Laboratories,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030159&THISHREF=http://c.moreover.com/click/here.pl%3fz2533474020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: